Target intelligence / Profile preview

Dural tissue interface

Molecular classification
Other
01

Overview

The dural tissue interface refers to the anatomical and physiological boundary between the dura mater—the outermost and most robust layer of the meninges—and its adjacent structures, including the inner table of the skull and the underlying arachnoid mater. This interface is critical for the structural integrity of the central nervous system, acting as a primary barrier that contains cerebrospinal fluid (CSF) and protects the brain and spinal cord from mechanical injury and infection (StatPearls, 2023). Beyond its mechanical role, the dural interface is a dynamic site for immune surveillance and metabolic waste clearance via the dural lymphatic system, which has recently emerged as a key pathway for CNS homeostasis (Nature, 2017). In clinical practice, this interface is a major focus for neurosurgical interventions, where synthetic or biological sealants are applied to repair dural defects and prevent debilitating CSF leaks (Journal of Neurosurgery, 2019). Furthermore, the dural tissue is densely populated with nociceptors and vascular receptors, such as the calcitonin gene-related peptide (CGRP) receptor, making it a primary site of action for migraine therapies like triptans and CGRP antagonists (The Lancet Neurology, 2018). Understanding the dural tissue interface is essential for developing neuro-interventional devices, drug delivery systems to the CNS, and treatments for dural-related pathologies.

Other names
Dural-arachnoid interfaceDural-skull interfaceMeningeal interfaceDural-CSF interfaceDural border cell layerDural-lymphatic interface
02

Mechanism of action

Physical barrier formation and nociceptive signaling modulation

03

Biological functions

Physical protectionCerebrospinal fluid containmentImmune surveillanceWaste clearance
04

Disease associations

Cerebrospinal fluid leakMigraineSubdural hematomaMeningitis
05

Safety considerations

Postoperative infectionInflammatory responseAdhesion formationCompression of neural structures
06

Interacting drugs

Polyethylene glycol sealant (DuraSeal)

4 more in the full profile.

07

Biomarkers

Beta-2 transferrinBeta-trace proteinIntracranial pressure

Beyond the preview

Go deeper on Dural tissue interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dural tissue interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call